The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania’s Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.
Apple and Nokia set aside their differences and reached a business deal to end sprawling patent litigation that accused the California-based iPhone maker of infringing 40 Nokia patents for video coding, compression and other technologies, the companies said Tuesday.
Truck and equipment dealers and other buyers of vehicles transported by maritime shipping companies on Tuesday asked the U.S. Supreme Court to overturn a Third Circuit ruling that shipping companies are immune from allegations of a conspiracy to stifle competition and fix prices for vehicle transportation.
The Chicago Cubs and a group of Wrigley Field-area rooftop owners went before the Seventh Circuit on Tuesday to argue whether the baseball team broke a contract when it broke the owners' stadium sight lines in an alleged bid to monopolize game views.
A Manhattan federal judge sought Tuesday to assess the size of a potential class action alleging a dozen megabanks including Goldman Sachs Group Inc. and Bank of America Corp. colluded to block startup trading platforms from entering the giant market for interest rate swaps, after a plaintiffs-side lawyer alluded to potential billion-dollar damages.
The U.S. Department of Justice’s antitrust division and the Federal Trade Commission on Tuesday recommended that their funding levels be kept mostly the same in fiscal year 2018 but proposed to reduce staffing following President Donald Trump’s request for government agencies to cut federal workers.
End payors on Monday asked a Michigan federal judge to approve a proposed $7.6 million deal to settle claims in multidistrict litigation that an automotive bearings supplier and its Swedish affiliates participated in a price-fixing scheme with manufacturers in the U.S., Japan and Germany.
A New Jersey federal judge on Tuesday gave his preliminary approval to a $60.2 million settlement among Merck & Co. Inc., Upsher-Smith Laboratories Inc. and direct purchasers of the potassium supplement K-Dur, which will end long-running multidistrict litigation accusing the drug companies of engaging in a pay-for-delay scheme.
Forty states on Monday defended their lawsuit against six generic-drug manufacturers alleging they divided the market and fixed the price of an antibiotic and a diabetes treatment, saying they have the authority to seek an injunction and monetary relief under federal antitrust law.
The U.K.'s Competition and Markets Authority provisionally found Tuesday that pharmaceutical company Merck Sharp & Dohme Ltd. has operated an anti-competitive discount scheme for its popular brand-name arthritis medicine Remicade in an attempt to keep rival generic drugs off the market.
A Pennsylvania federal judge has agreed to trim damage calculations put forward by an expert for Apotex Inc. in a dispute over how it was impacted by generic Provigil pay-for-delay deals it is challenging in court, ruling that two of the three offered calculations that relied on questionable assumptions.
The investors who sued several big financial institutions for allegedly rigging interbank loan rates asked a New York federal judge Monday to claim jurisdiction over their litigation with Deutsche Bank and JPMorgan, arguing the case’s dismissal and pending appeal has created difficulties in finalizing settlements with the banks.
Sullivan & Cromwell LLP announced Monday it brought on Brussels-based competition partner Michael Rosenthal, formerly of Wilson Sonsini Goodrich & Rosati PC, to expand its global antitrust practice in the home of the European Union’s antitrust watchdog.
Massachusetts-based Concert Pharmaceuticals Inc. has received a second request for information from the Federal Trade Commission for the planned sale of its investigational cystic fibrosis treatment to Vertex Pharmaceuticals Inc. in a deal worth up to $250 million, the company said Monday.
GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. have refused to hand over crucial information such as Teva’s financial forecasts in a potential class action by buyers alleging that the companies conspired to delay generic competition for epilepsy treatment Lamictal, counsel for purchasers of the drug told a New Jersey federal court on Friday.
A New York judge has found an AIG unit does not have to defend Carfax against a $50 million suit alleging the company monopolized the vehicle history report market, saying references to defamation in the suit cannot get Carfax out from under an antitrust exclusion.
A D.C. federal court on Monday refused to block Visa and Mastercard from enforcing ATM fee rules that allegedly violate federal antitrust law, saying the National ATM Council failed to prove that the rules have caused the number of independent ATMs to decline.
The European Commission has decided to study competition in the loan syndication market in the U.K., Germany and four other European nations, citing the growing importance of the multi-lender offerings for leveraged buyouts and other large projects.
The United Kingdom’s Competition and Markets Authority said Monday it is launching an independent in-depth investigation into Euro Car Parts’ acquisition of another car parts supplier, Andrew Page Ltd., after the former failed to address the government’s competition concerns.
Facebook Inc. and Social Ranger LLC have tentatively reached a settlement in a suit alleging the social media giant used anti-competitive practices to dominate the virtual currency services market in social gaming, and a Delaware federal judge on Friday paused the case so the companies could finalize a deal.
The U.S. Supreme Court declined Monday to review a Fifth Circuit decision finding the Louisiana State Board of Nursing was immune from an antitrust suit by a former Grambling State University nursing student whose program was shut down.
Every lawyer who’s handled a civil case in federal court knows about Rule 30(b)(6), governing deposition procedures. But for many real-world deposition dilemmas, the rule offers little guidance. Last year, an Advisory Committee on Civil Rules subcommittee began considering whether the rule should be amended. Now attorneys must advise the subcommittee how to proceed, says Frank Silvestri Jr. of Verrill Dana LLP.
Anthem's decision to call off its proposed acquisition of Cigna — effectively mooting its appeal to the U.S. Supreme Court — leaves unanswered several important questions regarding the appropriate treatment of efficiencies in a merger challenge, say attorneys with Crowell & Moring LLP.
Despite an increase in engagement with client feedback programs over the last 15 years, law firms — and their clients — have a way to go before realizing the maximum benefits such programs can deliver, says Elizabeth Duffy of Acritas US Inc.
There are two approaches to Chinese law regarding failure to declare concentration — one is that businesses will no longer face anti-monopoly risk after two years, and the other is that they could still face risk after two years. As seen in the recent Cummins case, China's Ministry of Commerce clearly prefers the latter, say attorneys with Tian Yuan Law Firm.
Most law firms today aren't using common security and data protection measures that other industries employ to protect sensitive data. Options like continuous data replication and backups have various pros and cons, but most importantly, law practices must understand the need for a two-tiered approach to data protection, says Jeff Ton of Bluelock LLC.
U.S.-based companies distributing their products online or setting up e-retail platforms in the EU must pay particular attention to how they select online distribution partners, as well as what type of sales restrictions they impose or agree to, if they want to avoid legal trouble, says Enzo Marasà of Portolano Cavallo.
Justice Neil Gorsuch joined the U.S. Supreme Court a little more than 30 days ago, on April 7, 2017. And while it is too early for him to have written any opinions, Gorsuch participated in the final 13 oral arguments of the 2016 term. Charles Webber of Faegre Baker Daniels LLP offers five takeaways from his first month on the job.
U.S.-based manufacturers and retailers who want to sell in the EU face legal challenges in selecting and controlling their distribution networks, particularly with regard to online sales. All stakeholders must understand the restrictions imposed by Article 101 of the Treaty on the Functioning of the European Union, which prohibits anti-competitive agreements, says Enzo Marasà of Portolano Cavallo.
Although the end often comes quickly, law firms do not fail overnight. Randy Evans of Dentons and Elizabeth Whitney of Swiss Re Corporate Solutions review five mistakes that expedite law firm failures.
There are troubling provisions in proposed amendments to the Competition Law of the Socialist Republic of Vietnam. The approach to abuse of dominance is contrary to the teachings from modern economics, says Koren Wong-Ervin, director of the Global Antitrust Institute at George Mason University.